Biomarkers of systemic inflammation predict survival in stage III non-small cell lung cancer treated with chemoradiotherapy. (March 2022) - Langley, Benjamin; Leach, James; Fenner, Florence; Killean, Angus; Barrie, Colin; Maclennan, Kirsty; Campbell, Sorcha; Evans, Tamasin; Tufail, Aisha; Harrow, Stephen; McMenemy, Maria; MacKean, Melanie; et al.